| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Passage BIO, Inc. | Director | Director Stock Option (right to buy) | 47.7K | May 21, 2024 | Direct | ||
| Acumen Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 25K | Jun 10, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals, Inc. | Jun 10, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
| PASG | Passage BIO, Inc. | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| ABOS | Acumen Pharmaceuticals, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 7, 2023 | Director |
| PASG | Passage BIO, Inc. | May 25, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
| ABOS | Acumen Pharmaceuticals, Inc. | Jan 4, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
| ABOS | Acumen Pharmaceuticals, Inc. | Jan 4, 2023 | 0 | $0 | 3 | Jan 4, 2023 | Director |
| PASG | Passage BIO, Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
| PASG | Passage BIO, Inc. | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |
| PASG | Passage BIO, Inc. | May 27, 2021 | 0 | $0 | 3 | May 28, 2021 | Director |